Weighing in on Lilly’s tirzepatide vials

Medscape wonders how Lilly’s making tirzepatide available in vials will affect the GLP-1 market. Eli Lilly, of course, spewed its usual fearmongering about compounded versions, but Scott didn’t rise to the bait, but did point out that actually helping patients is a welcome change for Lilly.

You’ve probably seen the news that Eli Lilly will begin selling Zepbound in vials by mail. What you...

NPR station WHYY was one of many that covered the Hims & Hers Super Bowl ad, and one of many that...

APC helped push back against the California Board of Pharmacy’s plan to all but outlaw glutathione,...

Weighing in on Lilly’s tirzepatide vials

Related posts

Scott on Lilly on GLP-1s on CBS

Live on WHYY

Tenille talks about the cost of firefighters’ lives